Dexter — Distalmotion (Switzerland)

Who's exposed

Deployment status

Dexter comes from Distalmotion in Lausanne, Switzerland, and is one of the few robots that has cleared da Vinci's patent wall and actually reached the operating room. It took a different route: instead of a flagship platform that fills an entire OR, it built a compact, cart-mounted system that fits inside an ambulatory surgical center. As of 2026, Dexter has been used on more than 3,000 patients worldwide and sells commercially in both the US and Europe. In the US, the FDA cleared it for inguinal hernia repair (2024) and hysterectomy (2025); early installations include a surgeon-led ASC in Buffalo and a multi-robot agreement with a hospital in Orlando. In Europe it has an installed base in Switzerland, Austria, France, and Germany, with CE marking covering general surgery, gynecology, and urology.

When this hits the labor market

Surgical robots don't cut a job the way a warehouse robot does — they change where the patients go. Within 1-3 years, the real variable is the access threshold dropping: robotic surgery used to require a large hospital that could afford a da Vinci, and now an ambulatory surgical center can afford a Dexter. Whoever owns the machine pulls in the hernia, gynecology, and urology minimally invasive volume. Within 3-5 years that shift reshapes the training pipeline: surgeons fluent on the console get more cases, surgeons who only know open or conventional laparoscopy get fewer. What gets squeezed isn't the lead surgeon — it's the department structures and staffing built on conventional-technique case volume.

A robot built to get into the outpatient surgery center

For two decades the surgical-robot market had one name: da Vinci. Intuitive held the patents, the installed base, and the muscle memory of a whole generation of surgeons, and almost nobody broke through. Dexter is one of the few that did — and it picked an angle nobody else took seriously: rather than out-flagship da Vinci, it drove the cost and footprint of robotic surgery down.

Its strategy lives in one word: hybrid. Dexter doesn’t send the surgeon off to a separate console booth. It puts manual laparoscopy and robotic instruments at the same table, so the surgeon works by hand when that’s better and switches to the robotic arms when that is. The system is compact and cart-mounted, and it doesn’t require converting a room into a dedicated robotic OR. For a surgery center without a big budget or a spare operating room, those two facts decide whether the machine is affordable and installable at all — not marketing copy.

Where it’s installed today

Don’t let the “small Swiss company” framing mislead you. By 2026 Dexter has been used in more than 3,000 procedures, selling in the US and Europe at the same time. In the US the FDA cleared hernia repair (2024) and then hysterectomy (2025); early installs include a surgeon-owned ASC in Buffalo and a hospital in Orlando that signed for multiple units at once. In Europe there’s an installed base in Switzerland, Austria, France, and Germany, with CE marking across general surgery, gynecology, and urology.

Three thousand cases isn’t a scary number — da Vinci’s global total is many multiples of it. But Dexter proved something nobody else managed: outside Intuitive’s patent wall, you can in fact build a robot that clears the regulators, books orders, and aims squarely at the outpatient market everyone else ignored.

Why we care for LostJobs

Surgical robots are the least “job-stealing” category in this catalog, yet their employment effect is real — it just travels an indirect path. They don’t fire the lead surgeon; they change the distribution of surgical volume. What makes Dexter distinct is that it pushes that redistribution down to smaller institutions: once an ASC can afford a robot, the number of places that can offer robotic surgery jumps, and patient flow rearranges to follow it.

One level down, the pipeline changes. What residents and fellows train on decides which cases they’ll be qualified for in five years. A young surgeon who knows only open or conventional laparoscopic technique — and never worked the console — will find fewer operations open to them. What’s being reshaped isn’t a single job title; it’s the shape of the whole surgical training ladder. If you work inside a health system, where the equipment lands and who learns to run it tells you more about the future employment map than any job posting will.